Event Details
American Heart Association (AHA) Scientific Sessions 2024
Nov 16 - Nov 18, 2024
Title: PALISADE: A Phase 3 Study to Assess the Efficacy and Safety of Plozasiran in adults with Genetically or Clinically-Defined Familial Chylomicronemia Syndrome (FCS) at high risk of Acute Pancreatitis (AP)
Date/Time: November 16, 2024, 2:04 pm CST
Presenter: Gerald Watts
Session: Featured Science: Novel Approaches to Managing Lipid Risk
Title: Plozasiran and Triglyceride Levels in Hypertriglyceridemia: Long-Term Efficacy and Safety Data from Subjects in an Open-Label Extension Trial (MUIR and SHASTA-2 OLE)
Date/Time: November 18, 2024, 10:45 am CST
Presenter: Christie Ballantyne
Session: New Insights in Lipids and lipid lowering therapies